Home/Filings/4/0001209191-21-056265
4//SEC Filing

Luo Allison 4

Accession 0001209191-21-056265

CIK 0001718852other

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 8:09 PM ET

Size

5.6 KB

Accession

0001209191-21-056265

Insider Transaction Report

Form 4
Period: 2021-09-08
Luo Allison
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-09-08+4,5004,500 total(indirect: By Spouse)
    Exercise: $25.45Exp: 2031-09-07Common Stock (4,500 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest in 12 equal monthly installments, commencing on September 1, 2021, subject to the Reporting Person's continued service with the Issuer through each vest date.

Issuer

Prometheus Biosciences, Inc.

CIK 0001718852

Entity typeother

Related Parties

1
  • filerCIK 0001849225

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 8:09 PM ET
Size
5.6 KB